BioCentury
ARTICLE | Clinical News

Ceprate SC stem cell concentration system: Began Phase II trial to show depletion of tumor cells from stem cell transplants, in 30 patients who have had high-do

March 20, 1995 8:00 AM UTC

CellPro Inc. (CPRO), Seattle Product: Ceprate SC stem cell concentration system, using avidin-biotin binding to select CD34 cells from peripheral blood Indication: Small cell lung cancer Status: Began...